login
login

Europe Daily Bulletin No. 13109

28 January 2023
Contents Publication in full By article 23 / 23
NEWS BRIEFS / Health
EMA recommends that Paxlovid be granted a standard European marketing authorisation

27/01/23 (Agence Europe)Following the meeting of its Committee for Medicinal Products for Human Use (CMPH) on 23-26 January, the European Medicines Agency (EMA) announced on Friday 27 January that it recommended converting the conditional marketing authorisation for Paxlovid, granted on 28 January 2022 by the European Commission (see EUROPE B12879A27), to a standard marketing authorisation. Paxlovid is an orally active antiviral drug composed of nirmatrelvir and ritonavir,...

Contents

Russian invasion of Ukraine
SECTORAL POLICIES
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
SOCIAL AFFAIRS
COUNCIL OF EUROPE
NEWS BRIEFS